What is the difference between research and discovery in this directory?

Research = institutional capacity (universities, public institutes, translational centers, science parks). Drug Discovery = company-owned IP and pipelines. A research institute generates fundamental knowledge and may translate it into spin-outs; a discovery company commercializes specific candidates.

Which European institutions lead biotech research?

Germany hosts the deepest non-profit infrastructure (DKFZ, MDC, Helmholtz Munich, MPI). Switzerland: ETH Zurich, EPFL, Roche Innovation Center. Sweden: Karolinska Institutet, SciLifeLab. Lithuania: Vilnius University Life Sciences Center. Estonia: University of Tartu, Estonian Genome Project. Each institution interfaces with the surrounding industry via translational programs.

How are research organizations verified in this directory?

Every profile is hand-reviewed: institutional identity confirmed by primary source, physical site address sourced from official disclosures, research focus and program scope backed by published documentation, and a registry note explaining current research focus and industry-relevance.

Category and country

Research companies in Lithuania

6 research profiles in Lithuania. Every profile is hand-reviewed with leadership, certifications, and public sources.

All Lithuania biotech Research across Europe

Profiles6

Verified6

With certifications2

Cities4

Category view

Where does research cluster in Lithuania?

Vilnius (3), Kaunas (1), Klaipeda (1), and Klaipėda (1) Most visible profiles: Klaipeda University Health Research and Innovation Science Centre, LSMU Kaunas Clinics Biobank (Human Biological Resources Centre), Stem Cell Research Center (SCRC), and Inobiostar.

Category view

Which standards are already visible?

GLP (2) Latest review: 24 April 2026. Review cycle: April 2026.

Full list

Research profiles in Lithuania

6 profiles match the active filter.

Klaipeda University research centre conducting biomedical and public-health research under contract with Lithuanian and foreign partners, publishing peer-reviewed outputs and organizing international conferences.

Lead: Birute StrukcinskieneChief Researcher and Professor of Public Health
Scale: University research service delivery

Lithuanian University of Health Sciences (LSMU) biobank at Kaunas Clinics operating as one of four national BioBank repositories for solid tissue, liquid tissue, live tissue, and health information database samples.

Lead: Dalia PangonyteProfessor and BioBank Lead, LSMU
Scale: National biobanking operations

Vilnius Stem Cell Research Center managing the Lithuanian Stem Cell and Regenerative Medicine Cluster, with a disclosed 27 million EUR investment plan at Northtown and a 3D bioprinting research axis under the Northway group.

Lead: Vladas Algirdas BumelisFounder and Chairman of the Board, Northway group
Scale: Research center and cluster operations

Klaipėda deep-tech spinout developing blue-biotech and environmental-biotechnology solutions, including oil-spill treatment, aerogel materials, and marine innovation projects.

Lead: Tatjana PaulauskienėDirector
Scale: Early-stage applied biotechnology and innovation platform

Vilnius national research institute spanning materials science, photonics, chemistry, and applied life-science instrumentation.

Lead: Assoc. Prof. Dr. Rimantas RamanauskasGeneral Director
Scale: Large interdisciplinary research institute

Vilnius University flagship life-science campus integrating biochemistry, molecular biology, biotechnology, and training infrastructure.

Lead: Assoc. Prof. Dr. Eugenijus ButkusHead of Center
Scale: University life-science flagship campus

Related brief

Read deeper on this category

Regulatory brief

EU Biotech Regulation 2026: What Changed and Who It Affects

A plain reading of the 2026 EU biotech regulatory package — pharmaceutical reform, the European Health Data Space, the AI Act, and the upcoming EU Biotech Act — and what biotech, pharma, and CDMO companies should do about it.

Open brief

FAQ

Frequently asked questions on this category

What is the difference between research and discovery in this directory?: Research = institutional capacity (universities, public institutes, translational centers, science parks). Drug Discovery = company-owned IP and pipelines. A research institute generates fundamental knowledge and may translate it into spin-outs; a discovery company commercializes specific candidates.
Which European institutions lead biotech research?: Germany hosts the deepest non-profit infrastructure (DKFZ, MDC, Helmholtz Munich, MPI). Switzerland: ETH Zurich, EPFL, Roche Innovation Center. Sweden: Karolinska Institutet, SciLifeLab. Lithuania: Vilnius University Life Sciences Center. Estonia: University of Tartu, Estonian Genome Project. Each institution interfaces with the surrounding industry via translational programs.
How are research organizations verified in this directory?: Every profile is hand-reviewed: institutional identity confirmed by primary source, physical site address sourced from official disclosures, research focus and program scope backed by published documentation, and a registry note explaining current research focus and industry-relevance.

Next step

Compare companies or open the wider market.

Use the compare tool to view two or three companies side by side, or open the country hub for the full market view.

Open compare Open Vilnius Suggest a company